Gastrointestinal Symptom Cluster is Associated With Epigenetic Regulation of Lymphotoxin Beta in Oncology Patients Receiving Chemotherapy

Abstract

Objectives

While the gastrointestinal symptom cluster (GISC) is common in patients receiving chemotherapy, limited information is available on its underlying mechanism(s). Emerging evidence suggests a role for inflammatory processes through the actions of the nuclear factor kappa B (NF-κB) signaling pathway. This study evaluated for associations between a GISC and levels of DNA methylation for genes within this pathway.

Methods

Prior to their second or third cycle of chemotherapy, 1071 outpatients reported symptom occurrence using the Memorial Symptom Assessment Scale. A GISC was identified using exploratory factor analysis. Differential methylation analyses were performed in two independent samples using EPIC (n = 925) and 450K (n = 146) microarrays. Trans expression-associated CpG (eCpG) loci for 56 NF-κB signaling pathway genes were evaluated. Loci significance were assessed using an exploratory false discovery rate (FDR) of 25% for the EPIC sample. For the validation assessment using the 450K sample, significance was assessed at an unadjusted p-value of 0.05.

Results

For the EPIC sample, the GISC was associated with increased expression of lymphotoxin beta (LTB) at one differentially methylated trans eCpG locus (cg03171795; FDR = 0.168). This association was not validated in the 450K sample.

Conclusions

This study is the first to identify an association between a GISC and epigenetic regulation of a gene that is involved in the initiation of gastrointestinal immune responses. Findings suggest that increased LTB expression by hypermethylation of a trans eCpG locus is involved in the occurrence of this cluster in patients receiving chemotherapy. LTB may be a potential therapeutic target for this common cluster.

Keywords

cancer chemotherapy DNA methylation gastrointestinal symptom cluster inflammation nausea

Get full access to this article

View all access options for this article.

References

Agyekum

Church

Sohail

Krausz

Van Noorden

Polak

Cohen

(2003). Expression of lymphotoxin-beta (LT-beta) in chronic inflammatory conditions. The Journal of Pathology, 199(1), 115–121. https://doi.org/10.1002/path.1249

Andersson

Sandelin

Danko

C. G.

(2015). A unified architecture of transcriptional regulatory elements. Trends in Genetics, 31(8), 426–433. https://doi.org/10.1016/j.tig.2015.05.007

Aryee

M. J.

Jaffe

A. E.

Corrada-Bravo

Ladd-Acosta

Feinberg

A. P.

Hansen

K. D.

Irizarry

R. A.

(2014). Minfi: A flexible and comprehensive bioconductor package for the analysis of infinium DNA methylation microarrays. Bioinformatics, 30(10), 1363–1369. https://doi.org/10.1093/bioinformatics/btu049

Benjamini

Hochberg

(1995). Controlling the false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society. Series B (Methodological), 57(1), 289–300. https://doi.org/10.1111/j.2517-6161.1995.tb02031.x

Bock

(2012). Analysing and interpreting DNA methylation data. Nature Reviews Genetics, 13(10), 705–719. https://doi.org/10.1038/nrg3273

Borelli

Irla

(2021). Lymphotoxin: From the physiology to the regeneration of the thymic function. Cell Death & Differentiation, 28(8), 2305–2314. https://doi.org/10.1038/s41418-021-00834-8

Bowen

J. M.

Gibson

R. J.

Tsykin

Stringer

A. M.

Logan

R. M.

Keefe

D. M.

(2007). Gene expression analysis of multiple gastrointestinal regions reveals activation of common cell regulatory pathways following cytotoxic chemotherapy. International Journal of Cancer, 121(8), 1847–1856. https://doi.org/10.1002/ijc.22895

Brown

(2015). The common factor model and exploratory factor analysis (2nd ed.). The Guilford Press.

Carlotto

Hogsett

V. L.

Maiorini

E. M.

Razulis

J. G.

Sonis

S. T.

(2013). The economic burden of toxicities associated with cancer treatment: Review of the literature and analysis of nausea and vomiting, diarrhoea, oral mucositis and fatigue. PharmacoEconomics, 31(9), 753–766. https://doi.org/10.1007/s40273-013-0081-2

10.

Chen

M. L.

Lin

C. C.

(2007). Cancer symptom clusters: A validation study. Journal of Pain & Symptom Management, 34(6), 590–599. https://doi.org/10.1016/j.jpainsymman.2007.01.008

11.

Chen

Y. A.

Lemire

Choufani

Butcher

D. T.

Grafodatskaya

Zanke

B. W.

Gallinger

Hudson

T. J.

Weksberg

(2013). Discovery of cross-reactive probes and polymorphic CpGs in the illumina infinium humanmethylation450 microarray. Epigenetics, 8(2), 203–209. https://doi.org/10.4161/epi.23470

12.

Cinausero

Aprile

Ermacora

Basile

Vitale

M. G.

Fanotto

Parisi

Calvetti

Sonis

S. T.

(2017). New frontiers in the pathobiology and treatment of cancer regimen-related mucosal injury. Frontiers in Pharmacology, 8, 354. https://doi.org/10.3389/fphar.2017.00354

13.

Donovan

H. S.

Hagan

T. L.

Campbell

G. B.

Boisen

M. M.

Rosenblum

L. M.

Edwards

R. P.

Bovbjerg

D. H.

Horn

C. C.

(2016). Nausea as a sentinel symptom for cytotoxic chemotherapy effects on the gut-brain axis among women receiving treatment for recurrent ovarian cancer: An exploratory analysis. Supportive Care in Cancer, 24(6), 2635–2642. https://doi.org/10.1007/s00520-015-3071-4

14.

Kibbe

W. A.

Lin

S. M.

(2008). Lumi: A pipeline for processing illumina microarray. Bioinformatics, 24(13), 1547–1548. https://doi.org/10.1093/bioinformatics/btn224

15.

Zhang

Huang

Jafari

Kibbe

W. A.

Hou

Lin

S. M.

(2010). Comparison of beta-value and M-value methods for quantifying methylation levels by microarray analysis. Bioinformatics, 1(587), 1–9. https://doi.org/10.1186/1471-2105-11-587

16.

ENCODE Project Consortium (2012). An integrated encyclopedia of DNA elements in the human genome. Nature, 489(7414), 57–74. https://doi.org/10.1038/nature11247

17.

Ernst

Kheradpour

Mikkelsen

T. S.

Shoresh

Ward

L. D.

Epstein

C. B.

Zhang

Wang

Issner

Coyne

Durham

Kellis

Bernstein

B. E.

(2011). Mapping and analysis of chromatin state dynamics in nine human cell types. Nature, 473(7345), 43–49. https://doi.org/10.1038/nature09906

18.

Extermann

Bonetti

Sledge

G. W.

O’Dwyer

P. J.

Bonomi

Benson

A. B.

3rd (2004). MAX2 – A convenient index to estimate the average per patient risk for chemotherapy toxicity; validation in ECOG trials. European Journal of Cancer, 40(8), 1193–1198. https://doi.org/10.1016/j.ejca.2004.01.028

19.

Gibson

R. J.

Keefe

D. M.

(2006). Cancer chemotherapy-induced diarrhoea and constipation: Mechanisms of damage and prevention strategies. Supportive Care in Cancer, 14(9), 890–900. https://doi.org/10.1007/s00520-006-0040-y

20.

Gubernatorova

E. O.

Tumanov

A. V.

(2016). Tumor necrosis factor and lymphotoxin in regulation of intestinal inflammation. Biochemistry (Mosc), 81(11), 1309–1325. https://doi.org/10.1134/S0006297916110092

21.

Harris

C. S.

Miaskowski

C. A.

Dhruva

A. A.

Cataldo

Kober

K. M.

(2021). Multi-staged data-integrated multi-omics analysis for symptom science research. Biological Research for Nursing, 23(4), 596–607. https://doi.org/10.1177/10998004211003980

22.

Harris

C. S.

Kober

K. M.

Conley

Y. P.

Dhruva

A. A.

Hammer

Miaskowski

C. A.

(2022). Symptom clusters in patients receiving chemotherapy: A systematic review. BMJ Supportive & Palliative Care, 12(1), 10–21. https://doi.org/10.1136/bmjspcare-2021-003325

23.

Harris

C. S.

Kober

K. M.

Cooper

Conley

Y. P.

Dhruva

A. A.

Hammer

M. J.

Paul

Levine

J. D.

Miaskowski

C. A.

(2022). Symptom clusters in outpatients with cancer using different dimensions of the symptom experience. Supportive Care in Cancer, 30(8), 6889–6899. https://doi.org/10.1007/s00520-022-07125-z

24.

Jones

M. J.

Goodman

S. J.

Kobor

M. S.

(2015). DNA methylation and healthy human aging. Aging Cell, 14(6), 924–932. https://doi.org/10.1111/acel.12349

25.

Jones

P. A.

(2012). Functions of DNA methylation: Islands, start sites, gene bodies and beyond. Nature Reviews Genetics, 13(7), 484–492. https://doi.org/10.1038/nrg3230

26.

Jungbeck

Stopfer

Bataille

Nedospasov

S. A.

Mannel

D. N.

Hehlgans

(2008). Blocking lymphotoxin beta receptor signalling exacerbates acute DSS-induced intestinal inflammation—opposite functions for surface lymphotoxin expressed by T and B lymphocytes. Molecular Immunology, 45(1), 34–41. https://doi.org/10.1016/j.molimm.2007.05.007

27.

Kanehisa

Goto

(2000). KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Research, 28(1), 27–30. https://doi.org/10.1093/nar/28.1.27

28.

Karnofsky

(1977). Performance scale. In Kennealey

Mitchell

(Eds.), Factors that influence the therapeutic response in cancer: A comprehensive treatise. Plenum Press.

29.

Karnuta

J. M.

Scacheri

P. C.

(2018). Enhancers: Bridging the gap between gene control and human disease. Human Molecular Genetics, 27(R2), R219–R227. https://doi.org/10.1093/hmg/ddy167

30.

Kennedy

E. M.

Goehring

G. N.

Nichols

M. H.

Robins

Mehta

Klengel

Eskin

Smith

A. K.

Conneely

K. N.

(2018). An integrated -omics analysis of the epigenetic landscape of gene expression in human blood cells. BMC Genomics, 19(1), 476. https://doi.org/10.1186/s12864-018-4842-3

31.

Kent

W. J.

Sugnet

C. W.

Furey

T. S.

Roskin

K. M.

Pringle

T. H.

Zahler

A. M.

Haussler

(2002). The human genome browser at UCSC. Genome Research, 12(6), 996–1006. https://doi.org/10.1101/gr.229102

32.

Kober

Lee

M.-C.

Olshen

Conley

Sirota

Keiser

Hammer

Abrams

Schumacher

Levine

Miaskowski

(2020). Differential methylation and expression of genes in the hypoxia inducible factor 1 (HIF-1) signaling pathway are associated with paclitaxel-induced peripheral neuropathy in breast cancer survivors and with preclinical models of chemotherapy-induced neuropathic pain. Molecular Pain, 16(1744806920936502), 174480692093650. https://doi.org/10.1177/1744806920936502

33.

Leek

J. T.

Storey

J. D.

(2007). Capturing heterogeneity in gene expression studies by surrogate variable analysis. Plos Genetics, 3(9), 1724–1735. https://doi.org/10.1371/journal.pgen.0030161

34.

Matzka

Köck-Hódi

Jahn

Mayer

(2018). Relationship among symptom clusters, quality of life, and treatment-specific optimism in patients with cancer. Supportive Care in Cancer, 26(8), 2685–2693. https://doi.org/10.1007/s00520-018-4102-8

35.

McGregor

Bernatsky

Colmegna

Hudson

Pastinen

Labbe

Greenwood

C. M.

(2016). An evaluation of methods correcting for cell-type heterogeneity in DNA methylation studies. Genome Biology, 17(1), 84. https://doi.org/10.1186/s13059-016-0935-y

36.

Molassiotis

Wengstrom

Kearney

(2010). Symptom cluster patterns during the first year after diagnosis with cancer. Journal of Pain & Symptom Management, 39(5), 847–858. https://doi.org/10.1016/j.jpainsymman.2009.09.012

37.

Muthén

(2019). Mplus (Version 8.4). Muthen & Muthen.

38.

Oeckinghaus

Ghosh

(2009). The NF-kappaB family of transcription factors and its regulation. Cold Spring Harbor Perspectives in Biology, 1(4), a000034. https://doi.org/10.1101/cshperspect.a000034

39.

Papachristou

Barnaghi

Cooper

Kober

K. M.

Maguire

Paul

S. M.

Hammer

Wright

Armes

Furlong

E. P.

McCann

Conley

Y. P.

Patiraki

Katsaragakis

Levine

J. D.

Miaskowski

(2019). Network analysis of the multidimensional symptom experience of oncology. Scientific Reports, 9(1), 1–11. https://doi.org/10.1038/s41598-018-36973-1

40.

Pirri

Bayliss

Trotter

Olver

I. N.

Katris

Drummond

Bennett

(2013). Nausea still the poor relation in antiemetic therapy? The impact on cancer patients’ quality of life and psychological adjustment of nausea, vomiting and appetite loss, individually and concurrently as part of a symptom cluster. Supportive Care in Cancer, 21(3), 735–748. https://doi.org/10.1007/s00520-012-1574-9

41.

Pisani

L. F.

Tontini

Vecchi

Croci

G. A.

Pastorelli

(2022). NF-kB pathway is involved in microscopic colitis pathogenesis. The Journal of International Medical Research, 50(3), 3000605221080104. https://doi.org/10.1177/03000605221080104

42.

Portela

Esteller

(2010). Epigenetic modifications and human disease. Nature Biotechnology, 28(10), 1057–1068. https://doi.org/10.1038/nbt.1685

43.

Portenoy

R. K.

Thaler

H. T.

Kornblith

A. B.

Lepore

J. M.

Friedlander-Klar

Kiyasu

Sobel

Coyle

Kemeny

Norton

Scher

(1994). The memorial symptom assessment scale: An instrument for the evaluation of symptom prevalence, characteristics and distress. European Journal of Cancer, 30A(9), 1326–1336. https://doi.org/10.1016/0959-8049(94)90182-1

44.

Rakyan

V. K.

Down

T. A.

Balding

D. J.

Beck

(2011). Epigenome-wide association studies for common human diseases. Nature Reviews Genetics, 12(8), 529–541. https://doi.org/10.1038/nrg3000

45.

Ren

Tang

Zhao

Ren

(2017). Symptom clusters and related factors in bladder cancer patients three months after radical cystectomy. BMC Urology, 17(1), 65. https://doi.org/10.1186/s12894-017-0255-x

46.

Ritchie

M. E.

Phipson

Law

C. W.

Shi

Smyth

G. K.

(2015). Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Research, 43(7), e47. https://doi.org/10.1093/nar/gkv007

47.

Rosenbloom

K. R.

Sloan

C. A.

Malladi

V. S.

Dreszer

T. R.

Learned

Kirkup

V. M.

Wong

M. C.

Maddren

Fang

Heitner

S. G.

Lee

B. T.

Barber

G. P.

Harte

R. A.

Diekhans

Long

J. C.

Wilder

S. P.

Zweig

A. S.

Karolchik

Kuhn

R. M.

Haussler

Kent

W. J.

(2013). ENCODE data in the UCSC genome browser: Year 5 update. Nucleic Acids Research, 41(D1), D56–D63. https://doi.org/10.1093/nar/gks1172

48.

Salas

Koestler

(2021). FlowSorted.Blood.EPIC: Illumina EPIC data on immunomagnetic sorted peripheral adult blood cells. (Version 1.12.1) R package. https://github.com/immunomethylomics/FlowSorted.Blood.EPIC

49.

Salas

L. A.

Koestler

D. C.

Butler

R. A.

Hansen

H. M.

Wiencke

J. K.

Kelsey

K. T.

Christensen

B. C.

(2018). An optimized library for reference-based deconvolution of whole-blood biospecimens assayed using the Illumina HumanMethylationEPIC BeadArray. Genome Biology, 19(1), 64. https://doi.org/10.1186/s13059-018-1448-7

50.

Sangha

Stucki

Liang

M. H.

Fossel

A. H.

Katz

J. N.

(2003). The self-administered comorbidity questionnaire: A new method to assess comorbidity for clinical and health services research. Arthritis & Rheumatism, 49(2), 156–163. https://doi.org/10.1002/art.10993

51.

Sedy

Bekiaris

Ware

C. F.

(2014). Tumor necrosis factor superfamily in innate immunity and inflammation. Cold Spring Harbor Perspectives in Biology, 7(4), a016279. https://doi.org/10.1101/cshperspect.a016279

52.

Shi

J. H.

Sun

S. C.

(2018). Tumor necrosis factor receptor-associated factor regulation of nuclear factor kappaB and mitogen-activated protein kinase pathways. Frontiers in Immunology, 9(■), 1849. https://doi.org/10.3389/fimmu.2018.01849

53.

Singh

K. P.

Dhruva

Flowers

Paul

S. M.

Hammer

M. J.

Wright

Cartwright

Conley

Y. P.

Melisko

Levine

J. D.

Miaskowski

Kober

K. M.

(2020). Alterations in patterns of gene expression and perturbed pathways in the gut-brain axis are associated with chemotherapy-induced nausea. Journal of Pain & Symptom Management, 59(6), 1248–1259. https://doi.org/10.1016/j.jpainsymman.2019.12.352

54.

Singh

Kober

K. M.

Paul

S. M.

Hammer

Wright

Conley

Y. P.

Levine

J. D.

Miaskowski

(2020). Gastrointestinal symptoms are associated with trajectories of chemotherapy-induced nausea. Supportive Care in Cancer, 28(5), 2205–2215. https://doi.org/10.1007/s00520-019-05031-5

55.

Singh

Cao

Miaskowski

Conley

Y. P.

Hammer

Wright

Levine

J. D.

Kober

K. M.

(2021). Perturbations in endocytotic and apoptotic pathways are associated with chemotherapy-induced nausea. Biological Research for Nursing, 23(2), 238–247. https://doi.org/10.1177/1099800420951271

56.

Skerman

H. M.

Yates

P. M.

Battistutta

(2012). Cancer-related symptom clusters for symptom management in outpatients after commencing adjuvant chemotherapy, at 6 months, and 12 months. Supportive Care in Cancer, 20(1), 95–105. https://doi.org/10.1007/s00520-010-1070-z

57.

Sonis

S. T.

Elting

L. S.

Keefe

Peterson

D. E.

Schubert

Hauer-Jensen

Bekele

B. N.

Raber-Durlacher

Donnelly

J. P.

Rubenstein

E. B.

Mucositis Study Section of the Multinational Association of Supportive Care in Cancer and the International Society for Oral Oncology (2004). Perspectives on cancer therapy-induced mucosal injury: Pathogenesis, measurement, epidemiology, and consequences for patients. Cancer, 100(9 Suppl), 1995–2025. https://doi.org/10.1002/cncr.20162

58.

Sonis

Haddad

Posner

Watkins

Fey

Morgan

T. V.

Mookanamparambil

Ramoni

(2007). Gene expression changes in peripheral blood cells provide insight into the biological mechanisms associated with regimen-related toxicities in patients being treated for head and neck cancers. Oral Oncology, 43(3), 289–300. https://doi.org/10.1016/j.oraloncology.2006.03.014

59.

Sonis

S. T.

(2002). Biologic role for nuclear factor-kappa B in disease and its potential involvement in mucosal injury associated with anti-neoplastic therapy. Critical Reviews in Oral Biology and Medicine, 13(5), 380–389. https://doi.org/10.1177/154411130201300502

60.

Stopfer

Obermeier

Dunger

Falk

Farkas

Janotta

Moller

Mannel

D. N.

Hehlgans

(2004). Blocking lymphotoxin-beta receptor activation diminishes inflammation via reduced mucosal addressin cell adhesion molecule-1 (MAdCAM-1) expression and leucocyte margination in chronic DSS-induced colitis. Clinical & Experimental Immunology, 136(1), 21–29. https://doi.org/10.1111/j.1365-2249.2004.02402.x

61.

Sullivan

C. W.

Leutwyler

Dunn

L. B.

Miaskowski

(2018). A review of the literature on symptom clusters in studies that included oncology patients receiving primary or adjuvant chemotherapy. Journal of Clinical Nursing, 27(3–4), 516–545. https://doi.org/10.1111/jocn.14057

62.

Suwisith

Hanucharururnkul

Dodd

Vorapongsathorn

Pongthavorakamol

Asavametha

(2008). Symptom clusters and functional status of women with breast cancer. Thai Journal of Nursing Research, 12(3), 153–165. https://doi.org/10.1016/j.ejon.2009.09.005

63.

Szklarczyk

Gable

A. L.

Lyon

Junge

Wyder

Huerta-Cepas

Simonovic

Doncheva

N. T.

Morris

J. H.

Bork

Jensen

L. J.

Mering

C. V.

(2019). STRING v11: Protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Research, 47(D1), D607–D613. https://doi.org/10.1093/nar/gky1131

64.

Upadhyay

Y. X.

(2013). Lymphotoxin signalling in immune homeostasis and the control of microorganisms. Nature Reviews. Immunology, 13(4), 270–279. https://doi.org/10.1038/nri3406

65.

Ware

C. F.

(2005). Network communications: Lymphotoxins, LIGHT, and TNF. Annual Review of Immunology, 23(1), 787–819. https://doi.org/10.1146/annurev.immunol.23.021704.115719

66.

Yang

G. S.

Jackson-Cook

C. K.

Starkweather

A. R.

Lynch Kelly

Archer

K. J.

Zou

Lyon

D. E.

(2020). Differential DNA methylation following chemotherapy for breast cancer is associated with lack of memory improvement at one year. Epigenetics, 15(5), 499–510. https://doi.org/10.1080/15592294.2019.1699695

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.13 MB